Document is current

Any future updates will be listed below

Correction: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGF R-2 signaling pathway in hepatocellular carcinoma

Crossref DOI link: https://doi.org/10.1186/s13046-023-02824-9

Published Online: 2023-09-30

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark